Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled
用户EO9nReo4Hj6s
1个月前
46
10
已完结
1. 系统已在2025-12-08 16:29:23对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-2600(25)00209-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260025002097
其他信息:
出版社: Elsevier BV
作者: Shun Lu; Oleksandr Vynnychenko; Yaroslav Kulyaba; Vladimer Kuchava; Aishah Ibrahim; Fedor Moiseenko; Cagatay Arslan; Duong Thanh Nguyen; Marina Petrovic; Irfan Cicin; Khatuna Bibichadze; Timucin Cil; Jianhua Shi; Omer Fatih Olmez; Miranda Gogishvili; Mehmet Artac; Hoang Gia Nguyen; Mark Cornfeld; Chuan Tian; Mihaela C Munteanu; Claudia V M Sette; Igor Bondarenko
